Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GPR132 | Q9UNW8 | 3/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.38 |
| ▸ | GRM5 | P41594 | 2/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3105922 | 0.90 | HTT (0.41) | FAAHMAPTKMT2AADRB1ADRB3 | |
| SCHEMBL3101778 | 0.88 | FAAH (0.49) | FAAHGPR132 | |
| SCHEMBL4499433 | 0.85 | FAAH (0.40) | FAAHMAPTKMT2AGRM8GRM7 | |
| SCHEMBL4486483 | 0.84 | FAAH (0.40) | FAAHMAPTKMT2AGRM8GRM7 | |
| SCHEMBL3103882 | 0.81 | GRM5 (0.41) | FAAHGPR132ADRB1ADRB3GRM5 | |
| SCHEMBL3103497 | 0.81 | RORC (0.45) | FAAHMAPTKMT2AGPR132ADRB1 | |
| SCHEMBL3114820 | 0.80 | HTT (0.44) | MAPTKMT2AGPR132PPARG | |
| SCHEMBL3104042 | 0.79 | KDM5A (0.44) | GPR132SGMS2 | |
| SCHEMBL3109428 | 0.78 | RORC (0.41) | FAAHMAPTKMT2AGPR132ADRB1 | |
| SCHEMBL3109204 | 0.78 | MEN1 (0.49) | MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | BASF SE (DE) | 2010-10-28 | — | — | US | claimed |
| EP-2219459-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2010-08-25 | — | — | EP | claimed |
| WO-2009063076-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2009-05-22 | — | — | WO | claimed |
| US-20100273649-A1 | Fungicidal Mixtures III | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-2219459-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2010-08-25 | — | — | EP | disclosed |
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541472-B2 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CROPSOLUTION, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| WO-2009063076-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2009-05-22 | — | — | WO | disclosed |
| US-20060094739-A1 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | ATP CAPITAL LP | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | CBR3, CBR1, NOX3 | FAAH 1152/4885MAPT 4862/4885KMT2A 3860/4885 |
| US-20060094739-A1 | 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides | CYP51A1, DDT, CYP21A2 | FAAH 300/4885MAPT 3631/4885KMT2A 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.